Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Tiotropium
Boehringer Ingelheim International GmbH
R03BB; R03BB04
Tiotropium
18 microgram(s)
Inhalation powder, hard capsule
Product subject to prescription which may be renewed (B)
Anticholinergics; tiotropium bromide
Marketed
2002-06-28
S8/IE-MT/PI/WS641 06/01/2022 PACKAGE LEAFLET: INFORMATION FOR THE USER SPIRIVA ® 18 MICROGRAM, INHALATION POWDER, HARD CAPSULE tiotropium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Spiriva 18 microgram is and what it is used for 2. What you need to know before you use Spiriva 18 microgram 3. How to use Spiriva 18 microgram 4. Possible side effects 5. How to store Spiriva 18 microgram 6. Contents of the pack and other information 1. WHAT SPIRIVA 18 MICROGRAM IS AND WHAT IT IS USED FOR Spiriva 18 microgram helps people who have chronic obstructive pulmonary disease (COPD) to breathe more easily. COPD is a chronic lung disease that causes shortness of breath and coughing. The term COPD is associated with the conditions chronic bronchitis and emphysema. As COPD is a chronic disease you should take Spiriva 18 microgram every day and not only when you have breathing problems or other symptoms of COPD. Spiriva 18 microgram is a long-acting bronchodilator that helps to open your airways and makes it easier to get air in and out of the lungs. Regular use of Spiriva 18 microgram can also help you when you have on- going shortness of breath related to your disease and will help you to minimise the effects of the disease on your everyday life. It also helps you to be active longer. Daily use of Spiriva 18 microgram will also help to prevent sudden, short-term worsening of your COPD symptoms which may last for several days. The effect of this medicine lasts for 24 hours, so you only need to use it onc Lugege kogu dokumenti
HealthProductsRegulatoryAuthority 27April2023 CRN00D3D8 Page1of14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Spiriva18microgram,inhalationpowder,hardcapsule 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Eachcapsulecontains22.5microgramtiotropiumbromidemonohydrateequivalentto18microgramtiotropium. Thedelivereddose(thedosethatleavesthemouthpieceoftheHandiHaler ® device)is10microgramtiotropium. Excipientwithknowneffect: Eachcapsulecontains5.5milligramoflactose(asmonohydrate). Forthefulllistofexcipients,seesection6.1. 3 PHARMACEUTICAL FORM Inhalationpowder,hardcapsule. LightgreenhardcapsulescontainingtheinhalationpowderwiththeproductcodeTI01andcompanylogoprintedonthe capsule. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Spirivaisindicatedasamaintenancebronchodilatortreatmenttorelievesymptomsofpatientswithchronicobstructive pulmonarydisease(COPD). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Themedicinalproductisintendedforinhalationuseonly. TherecommendeddosageoftiotropiumbromideisinhalationofthecontentsofonecapsuleoncedailywiththeHandiHaler deviceatthesametimeofday. Therecommendeddoseshouldnotbeexceeded. Spirivacapsulesareonlyforinhalationandnotfororalintake. Spirivacapsulesmustnotbeswallowed. SpirivacapsulesshouldonlybeinhaledwiththeHandiHalerdevice. Special populations Geriatricpatientscanusetiotropiumbromideattherecommendeddose. Renallyimpairedpatientscanusetiotropiumbromideattherecommendeddose.Forpatientswithmoderat Lugege kogu dokumenti